CTD and eCTD Format MCQs With Answer helps M. Pharm students build a strong, practical understanding of global dossier structure and electronic submissions in Regulatory Affairs. The Common Technical Document (CTD) harmonizes quality, nonclinical, and clinical data presentation across ICH regions, while the electronic Common Technical Document (eCTD) standardizes digital submission, lifecycle management, and review. … Read more
Medical Device Regulation Basics MCQs With Answer helps M. Pharm (Regulatory Affairs) students test and strengthen their understanding of core global frameworks governing medical devices. This quiz covers the essentials across the U.S., EU, and India: device classification, premarket pathways, conformity assessment, quality systems, risk management, clinical evaluation, UDI, and postmarket surveillance. You will encounter … Read more
Regulation of combination products MCQs With Answer is designed for M. Pharm students taking Regulatory Affairs (MPH 104T). Combination products merge drugs, devices, and/or biologics into a single therapy, creating unique regulatory challenges across classification, submission strategy, quality systems, and postmarket oversight. This quiz focuses on core principles such as Primary Mode of Action (PMOA), … Read more
CMC and Post-Approval Changes MCQs With Answer is designed to help M. Pharm students consolidate critical aspects of Chemistry, Manufacturing, and Controls (CMC) and lifecycle change management in Regulatory Affairs (MPH 104T). This set focuses on ICH guidelines (Q8–Q12), FDA post-approval submission categories (PAS, CBE-30, CBE-0, Annual Report), EU Variations (Type IA/IB/II), SUPAC principles, comparability … Read more
US Registration Process MCQs With Answer for M. Pharm students are designed to strengthen your command over FDA pathways, documentation, timelines, and compliance obligations that drive U.S. drug approvals. This quiz distills key elements of the IND, NDA, ANDA, and BLA systems; eCTD structure; expedited programs (Fast Track, Breakthrough, Priority Review, Accelerated Approval); exclusivities; DMFs; … Read more
API, Biologics, Novel Therapy Approvals MCQs With Answer have been curated to help M. Pharm students master core regulatory pathways and quality requirements that drive modern drug development. This set covers key frameworks across the US, EU, and India—ranging from CTD/eCTD structure, DMFs, and CEPs for APIs to BLAs, biosimilar pathways, and ATMP classifications for … Read more
Outsourcing BA/BE studies MCQs With Answer is designed to help M. Pharm students master the regulatory, scientific, and operational nuances of outsourcing bioavailability/bioequivalence programs. From selecting and qualifying CROs to understanding global guidelines (FDA, EMA, ICH) and national regulations, this quiz covers end-to-end considerations such as study design, subject safety, data integrity, contracts, bioanalytical validation, … Read more
Scale-up and post-approval changes MCQs With Answer (Regulatory Affairs, MPH 104T) Scaling up a formulation and managing post-approval changes (SUPAC) are pivotal capabilities for M. Pharm students specializing in Regulatory Affairs. This MCQ set simplifies the complex regulatory expectations surrounding process and site changes, equipment and batch-size modifications, excipient and composition changes, and dossier filing … Read more
Bioequivalence and in-vivo studies MCQs With Answer Bioequivalence (BE) and in-vivo studies lie at the heart of regulatory approval pathways for generic and certain complex drug products. For M. Pharm students specializing in Regulatory Affairs, mastering BE concepts—study design, pharmacokinetic endpoints, statistics, bioanalytical validation, and ethical safeguards—is crucial for real-world dossier development. This set of … Read more
NDA Approval Process MCQs With Answer The New Drug Application (NDA) is the U.S. pathway to market a new drug, integrating evidence on quality, safety, and efficacy for FDA review. For M. Pharm students of Regulatory Affairs (MPH 104T), mastering the NDA process means understanding regulatory frameworks (21 CFR 314), the eCTD structure, user-fee timelines … Read more
